BBB NP Accountability Program Refers App Developer PlantSnap to Federal Trade Commission

Arlington, VA – October 8, 2019 – The BBB National Programs’ Digital Advertising Accountability Program referred the mobile app developer PlantSnap, Inc. to the Federal Trade Commission today. The referral was initiated after PlantSnap failed to participate in a self-regulatory review process looking into data privacy practices related to geolocation data and advertising.

The referral follows an inquiry by the Accountability Program into PlantSnap’s compliance with the Digital Advertising Alliance’s Self-Regulatory Principles, which are industry best practices for privacy in online advertising. The Accountability Program inquired into PlantSnap’s practices during routine technical monitoring of mobile apps for compliance with the DAA Principles involving the possible collection and use of data for interest-based advertising, including precise geolocation data. Interest-based advertising, also known as targeted advertising, uses this web- and app-derived data to infer people’s likely interests and serve ads to them on the basis of those interests.

“We are disappointed that PlantSnap did not respond to our repeated inquiries,” said Jon Brescia, vice president of the Accountability Program. “Our track record with companies has been overwhelmingly positive, with roughly 98% participation. Self-regulation relies on that kind of commitment—not just from the ad tech industry, but also from the publishers who interface directly with the end users.”

Today’s referral brings to 107 the number of public actions taken by the Accountability Program and the third referral of its existence.

 

Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.

 

 

 

 

Latest Decisions

Decision

National Advertising Division Recommends Dr. Luke Healthcare Discontinue Treatment Claims for its Fungal Nail Renewal Product

New York, NY – July 24, 2024 – The National Advertising Division recommended Dr. Luke Healthcare discontinue certain claims for Dr. Luke’s Fungal Nail Renewal product, including health-related claims, natural claims, and claims that a doctor recommends the product or that it treats a medical condition.

Read the Decision Summary
Decision

National Advertising Division Finds Flag Image on Kendamil Infant Formula Packaging Conveys Supported Message about Products’ Origin

New York, NY – July 17, 2024 – In a Fast-Track SWIFT challenge, the National Advertising Division determined that use of a flag image on product packaging for Kendal Nutricare’s Kendamil infant formula reasonably conveys a supported message about the products’ origin. 

Read the Decision Summary
Decision

In National Advertising Division Case, GuruNanda Voluntarily Discontinues Claims Made through Influencers for Coconut Pulling Oil Products

New York, NY – July 16, 2024 – The National Advertising Division has closed a Fast-Track SWIFT challenge regarding claims that GuruNanda’s coconut pulling oil products can “naturally reverse a cavity” and “reverse cavities.” 

Read the Decision Summary
Decision

National Advertising Division Refers Health-Related Advertising Claims for Prolacta’s Human Milk Fortifier to Regulatory Agencies

New York, NY – July 15, 2024 – The National Advertising Division will refer advertising claims made by Prolacta Bioscience for its Human Milk Fortifier to the Federal Trade Commission (FTC) and Food and Drug Administration (FDA) for review.

Read the Decision Summary